B. Clarke

发表

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

B. Clarke, S. Newton, A. Carroll, 1987, Nature.

Mapping of the Internal Ribosome Entry Site at the 5′ End of the Hepatitis C Virus Genome

R. Jackson, B. Clarke, D. Rowlands, 1994 .

Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus.

B. Clarke, S. Newton, A. Carroll, 1987, Nucleic acids research.

Developments in hepatitis C during 1996 - 1997

B. Clarke, M. Slater, 1997 .

The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus.

B. Clarke, A. Carroll, D. Rowlands, 1984, Nucleic acids research.

Immunological properties of hepatitis B core antigen fusion proteins.

B. Clarke, M. Francis, D. Rowlands, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Neutralization epitopes of human rhinovirus type 2.

J. Vadolas, B. Clarke, G. Appleyard, 1990, The Journal of general virology.

Approaches to the development of novel inhibitors of hepatitis C virus replication

B. Clarke, 1995, Journal of viral hepatitis.

Host cell selection of antigenic variants of foot-and-mouth disease virus.

B. Clarke, D. Rowlands, F. Brown, 1989, The Journal of general virology.

Two initiation sites for foot-and-mouth disease virus polyprotein in vivo.

B. Clarke, S. Newton, A. Carroll, 1985, The Journal of general virology.

All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs.

B. Clarke, S. Newton, D. Rowlands, 1987, Nucleic acids research.

Receptors for Hepatitis C Virus

B. Clarke, I. Jones, W. Jiang, 2000, Journal of Virology.

The sequence of foot-and-mouth disease virus RNA to the 5' side of the poly(C) tract.

B. Clarke, S. Newton, A. Carroll, 1985, Gene.

Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.

B. Clarke, L. Ogilvie, E. Rud, 1994, The Journal of general virology.

The nature and spatial distribution of amino acid substitutions conferring resistance to neutralizing monoclonal antibodies in human rhinovirus type 2.

B. Clarke, D. Rowlands, D. Sangar, 1993, The Journal of general virology.

In vitro cleavage of hepatitis C virus polyprotein substrates by purified recombinant NS3 protease.

B. Clarke, D. Rowlands, K. Grace, 1995, The Journal of general virology.

A new and improved method for 3′-end labelling DNA using [α-32P]ddATP

B. Clarke, A. Carroll, S. Yousaf, 1984 .

Mapping of neutralization epitopes of human rhinovirus type 2 with monoclonal antibodies

J. Vadolas, B. Clarke, G. Appleyard, 1989 .

TPIS – an IgE‐binding wheat protein

T. Brüning, B. Clarke, X. Baur, 2002, Allergy.

Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.

B. Clarke, D. Rowlands, F. Brown, 1989, The Journal of general virology.

Modification of the leader protein (Lb) of foot-and-mouth disease virus.

B. Clarke, A. Carroll, D. Rowlands, 1988, The Journal of general virology.

Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity.

B. Clarke, J. McKeating, N. Zitzmann, 2000, Virology.

The 5' untranslated region of GB virus B shows functional similarity to the internal ribosome entry site of hepatitis C virus.

B. Clarke, K. Grace, P. Karayiannis, 1999, The Journal of general virology.

Section Review Anti-infectives: Developments in viral hepatitis during 1995

B. Clarke, M. Slater, 1996 .

New drugs for hepatitis C virus (HCV).

B. Clarke, 2000, Bailliere's best practice & research. Clinical gastroenterology.

Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon.

R. Jackson, B. Clarke, A. Carroll, 1996, RNA.

Unique features of internal initiation of hepatitis C virus RNA translation.

R. Jackson, B. Clarke, A. Carroll, 1995, The EMBO journal.

Molecular genotyping of hepatitis B virus.

S. Bloor, B. Clarke, 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Induction of cytotoxic T‐cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

J. Prieto, G. Wilkinson, B. Clarke, 1997, Hepatology.

Localization of the mosaic transmembrane serine protease corin to heart myocytes.

B. Clarke, J. Hooper, T. Antalis, 2000, European journal of biochemistry.

A Steady-state and Pre-steady-state Kinetic Analysis of the NTPase Activity Associated with the Hepatitis C Virus NS3 Helicase Domain*

B. Clarke, D. J. Porter, F. Preugschat, 1996, The Journal of Biological Chemistry.

The complete nucteotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus

B. Clarke, D. Rowlands, A. Carrou, 2005 .

A high-molecular-weight fraction of smooth lipopolysaccharide in Klebsiella serotype O1:K20 contains a unique O-antigen epitope and determines resistance to nonspecific serum killing

C. Whitfield, B. Clarke, G. Schoenhals, 1989, Infection and immunity.

Molecular virology of hepatitis C virus.

B. Clarke, 1997, The Journal of general virology.

Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA.

M. Honda, L. Ping, S. Lemon, 1996, Virology.

An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect.

L. Ping, S. Lemon, B. Clarke, 1995, Virology.

Chemical basis of antigenic variation in foot-and-mouth disease virus

R. Lerner, R. Houghten, B. Clarke, 1983, Nature.

Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria.

B. Clarke, M. Francis, D. Rowlands, 1990, The Journal of general virology.

Multiple proteases in foot-and-mouth disease virus replication

B. Clarke, D. Rowlands, J. Burroughs, 1984, Journal of virology.

Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted.

B. Clarke, M. Francis, D. Rowlands, 1991, Vaccine.

Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions

G. Dougan, B. Clarke, M. Francis, 1996, Journal of virology.

A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2.

B. Clarke, A. Syred, D. Rowlands, 1987, The Journal of general virology.

An infectious molecular clone of a Japanese genotype 1b hepatitis C virus

M. Honda, S. Lemon, B. Clarke, 1999, Hepatology.

Stimulation of specific immune responses to simian immunodeficiency virus using chimeric hepatitis B core antigen particles.

B. Clarke, E. Rud, K. Kent, 1992, The Journal of general virology.

In vitro translation of hepatitis A virus subgenomic RNA transcripts.

S. Lemon, B. Clarke, D. Rowlands, 1991, The Journal of general virology.

Serological prospects for peptide vaccines against foot-and-mouth disease virus.

J. Fox, B. Clarke, M. Francis, 1989, The Journal of general virology.

Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro.

B. Clarke, D. Rowlands, E. D'Souza, 1994, The Journal of general virology.

Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.

C. Beddell, B. Clarke, M. Francis, 1990, Immunology.

The nucleotide sequence of the structural-protein-coding region of foot-and-mouth disease virus serotype SAT3.

B. Clarke, A. L. Brown, R. O. Campbell, 1989, Gene.

Expression in Yeast of Amino-Terminal Peptide Fusions to Hepatitis B Core Antigen and Their Immunological Properties

B. Clarke, M. Francis, F. Brown, 1990, Bio/Technology.

Developments in viral hepatitis during 1995

B. Clarke, M. Slater, Glaxo Wellcome, 1996 .

Processing and assembly of foot-and-mouth disease virus proteins using subgenomic RNA.

B. Clarke, D. Sangar, 1988, The Journal of general virology.

Peptide vaccines based on enhanced immunogenicity of peptide epitopes presented with T-cell determinants or hepatitis B core protein.

B. Clarke, M. Francis, 1989, Methods in enzymology.